Fact CheckerSign in

NCT06090422RecruitingPhase 1/2

Ketamine for depression and alcohol use disorder

Ketamine for combined depression and alcohol use disorder: A blinded randomized active placebo-controlled trial (the KeDA trial)

Source: EU CTIS (euclinicaltrials.eu) · Last updated 17 Jul 2026

Brief summary (registry, in English)

The primary objective is to assess the efficacy of ketamine for depression in adults with depression and AUD that are admitted for addiction therapy

Status (registry)
Recruiting
Phase (registry)
Phase 1/2
Study type
Interventional
Enrollment
34 (estimated)
First submitted
25 Oct 2023
Start date
20 Jan 2025
Lead sponsor
University Hospital Of North Norway HF
Diseases
Depression
NCT number
NCT06090422
EU CT number
2023-506052-24-00

What you commit to

  • Study type: Interventional · Phase 1/2
  • Planned participants: 34
  • 2 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study, not your situation.

Who cannot take part

Copied verbatim from EU CTIS (euclinicaltrials.eu) and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Previous anaphylactic reaction to the IMP or AMP

Other illness

  • Current or past history of psychotic disorder
  • Liver failure or impariment of liver function
  • Significant chronic kidney failure
  • Significant chronic heart failure
  • Significant chronic respiratory failure

Other

  • Not able to provide adequate informed consent
  • Illegal use of ketamine the last 6 months
  • Significant cardiovascular event during the last year

Who the study is looking for

  • 18-65 years of age
  • At least moderate depression without psychotic features
  • Alcohol dependence as their primary substance use disorder
  • Must be admitted to the hospital for inpatient addiction therapy at one of the inpatient units at University Hospital of North Norway

Age in the registry: 18 years to 64 years · Sex: All · Does not accept healthy volunteers

Full criteria on EU CTIS (euclinicaltrials.eu)

Sites (2)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Østfold Hospital Trust
Coordinator of this site? Confirm its status
GrålumNorwayRecruiting
Universitetssykehuset Nord-Norge HF
Coordinator of this site? Confirm its status
TromsoeNorwayRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.